 |
|
Autoradiographic Demonstration of Increased Serotonin 5-HT2 and β-Adrenergic Receptor Binding Sites in the Brain of Suicide Victims
Victoria Arango, PhD;
Paul Ernsberger, PhD;
Peter M. Marzuk, MD;
Jaw-Sy Chen, PhD;
Helen Tierney, MD;
Michael Stanley, PhD;
Donald J. Reis, MD;
J. John Mann, MD
Arch Gen Psychiatry. 1990;47(11):1038-1047.
Abstract
• Suicidal behavior has been linked to a deficiency in serotonin neurotransmission, but it is not known which brain regions are involved. We determined the pattern of alteration in serotonin 5-HT2 (5-HT2) receptor binding sites in suicide victims in prefrontal cortex compared with temporal cortex using a matched-pairs design to study 11 suicide victims and 11 matched controls, by both membrane binding and quantitative receptor autoradiography. Since a relationship between the serotonergic and noradrenergic systems has been proposed, we also examined β-adrenergic receptor binding sites. Binding to 5-HT2 and β-adrenergic sites in slide-mounted sections correlated strongly with binding site number in membrane preparations. A specific laminar distribution of 5-HT2 binding sites was found in both the control and suicide groups, whereas β-adrenergic binding sites did not differ across cortical layers. A significant increase was found in suicide victims across all cortical layers in both receptor subpopulations in the prefrontal cortex, but only β-adrenergic sites were increased in the temporal cortex. We conclude that suicide is associated with a localized increase in 5-HT2 binding sites.
Author Affiliations
From the Laboratory of Psychopharmacology, Department of Psychiatry (Drs Arango, Marzuk, Chen, Tierney, and Mann), and Division of Neurobiology, Department of Neurology (Drs Arango, Ernsberger, and Reis), Cornell University Medical College, and the Departments of Psychiatry and Pharmacology, College of Physicians and Surgeons, Columbia University (Dr Stanley), New York, NY. Drs Arango and Mann are now with the Laboratories of Neuropharmacology, Department of Psychiatry, University of Pittsburgh (Pa). Dr Ernsberger is now with the Division of Hypertension, Case Western Reserve University, Cleveland, Ohio.
Footnotes
Accepted for publication February 13, 1990.
This study was presented in part at the American Psychiatric Association Annual Meeting, Montreal, Canada, May 11, 1988; and the Society for Neuroscience Annual Meetings, New Orleans, La, November 17, 1987, and Toronto, Ontario, November 14, 1988.
Reprint requests to Laboratories of Neuropharmacology, Western Psychiatric Institute and Clinic, W1645 Biomedical Science Tower, University of Pittsburgh, 3811 O'Hara St, Pittsburgh, PA 15213 (Dr Arango).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Depression and History of Attempted Suicide as Risk Factors for Heart Disease Mortality in Young Individuals
Shah et al.
Arch Gen Psychiatry 2011;68:1135-1142.
ABSTRACT
| FULL TEXT
Obesity Linked to Smaller Cerebral Volume: What Should We Make of This?
Bremner
Psychosom. Med. 2009;71:483-484.
FULL TEXT
Chapter 48 Post-mortem studies of serotonin in suicide
Bach-Mizrachi et al.
Oxford Textbook of Suicidology and Suicide Prevention 2009;1:med-9780198570059-chapter-med-9780198570059-chapter.
ABSTRACT
| FULL TEXT
Changes in brain orexin levels in a rat model of depression induced by neonatal administration of clomipramine
Feng et al.
J Psychopharmacol 2008;22:784-791.
ABSTRACT
Brain Serotonin Transporter Binding Potential Measured With Carbon 11-Labeled DASB Positron Emission Tomography: Effects of Major Depressive Episodes and Severity of Dysfunctional Attitudes
Meyer et al.
Arch Gen Psychiatry 2004;61:1271-1279.
ABSTRACT
| FULL TEXT
Altered Gene Expression of Brain-Derived Neurotrophic Factor and Receptor Tyrosine Kinase B in Postmortem Brain of Suicide Subjects
Dwivedi et al.
Arch Gen Psychiatry 2003;60:804-815.
ABSTRACT
| FULL TEXT
Regional Brain Metabolic Correlates of {alpha}-Methylparatyrosine-Induced Depressive Symptoms: Implications for the Neural Circuitry of Depression
Bremner et al.
JAMA 2003;289:3125-3134.
ABSTRACT
| FULL TEXT
Mineralocorticoid Receptor Function in Major Depression
Young et al.
Arch Gen Psychiatry 2003;60:24-28.
ABSTRACT
| FULL TEXT
Molecular Abnormalities in Brains of Depressed Patients
Dowlatshahi and Young
Neuroscientist 2000;6:401-410.
ABSTRACT
Brain Serotonin2 Receptors in Major Depression: A Positron Emission Tomography Study
Yatham et al.
Arch Gen Psychiatry 2000;57:850-858.
ABSTRACT
| FULL TEXT
A Serotonin Transporter Gene Promoter Polymorphism (5-HTTLPR) and Prefrontal Cortical Binding in Major Depression and Suicide
Mann et al.
Arch Gen Psychiatry 2000;57:729-738.
ABSTRACT
| FULL TEXT
Serotonin, stress and corticoids
Chaouloff
J Psychopharmacol 2000;14:139-151.
ABSTRACT
Decrease in Brain Serotonin 2 Receptor Binding in Patients With Major Depression Following Desipramine Treatment: A Positron Emission Tomography Study With Fluorine-18-Labeled Setoperone
Yatham et al.
Arch Gen Psychiatry 1999;56:705-711.
ABSTRACT
| FULL TEXT
Effects of Tryptophan Depletion in Drug-Free Depressed Patients Who Responded to Total Sleep Deprivation
Neumeister et al.
Arch Gen Psychiatry 1998;55:167-172.
ABSTRACT
| FULL TEXT
S 15535, A Novel Benzodioxopiperazine Ligand of Serotonin (5-HT)1A Receptors: I. Interaction with Cloned Human (h)5-HT1A, Dopamine hD2/hD3 and halpha 2A-Adrenergic Receptors in Relation to Modulation of Cortical Monoamine Release and Activity in Models of Potential Antidepressant Activity
Millan et al.
J. Pharmacol. Exp. Ther. 1997;282:132-147.
ABSTRACT
| FULL TEXT
Positron Emission Tomography Measurement of Cerebral Metabolic Correlates of Tryptophan Depletion--Induced Depressive Relapse
Bremner et al.
Arch Gen Psychiatry 1997;54:364-374.
ABSTRACT
Serotonin and the Neurobiology of Depression: Effects of Tryptophan Depletion in Drug-Free Depressed Patients
Delgado et al.
Arch Gen Psychiatry 1994;51:865-874.
ABSTRACT
The Emergence of Suicidal Ideation and Behavior During Antidepressant Pharmacotherapy
Mann and Kapur
Arch Gen Psychiatry 1991;48:1027-1033.
ABSTRACT
|
